DR AGARWALS HEALTH CARE L Fair Value
AGARWALEYE · Healthcare · Current price ₹516.35
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹59 | 7% ROE fading to 13% over ~3 yrs, on ₹64 book |
| Relative P/E | ₹285 | EPS × 67.8 peer-median P/E |
| Graham floor | ₹78 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹584 | Street consensus 12-month target price |
Is DR AGARWALS HEALTH CARE L undervalued?
DocStoX estimates the fair value of DR AGARWALS HEALTH CARE L at ₹208 per share, versus the current market price of ₹516. That puts the stock about -59.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹59), Relative P/E (₹285), Graham floor (₹78), Analyst target (₹584). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹59 (bear) to ₹208 (base) to ₹584 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on DR AGARWALS HEALTH CARE L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.